Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 17q24 2 Microdeletion Syndrome C5680185
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 17q24 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
17q24 2 Microdeletion Syndrome C5680185
A rare genetic disorder caused by deletion of genetic material on chromosome 17. Individuals may have developmental delays, facial features, and other medical issues. Care is supportive and multidisciplinary.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
17q24 2 Microdeletion Syndrome C5680185
0-null
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
17q24 2 Microdeletion Syndrome C5680185
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
17q24 2 Microdeletion Syndrome C5680185
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
17q24 2 Microdeletion Syndrome C5680185
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
17q24 2 Microdeletion Syndrome C5680185
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
17q24 2 Microdeletion Syndrome C5680185
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 17q24-2-microdeletion-syndrome-C5680185 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 17q24 2 Microdeletion Syndrome C5680185 | Discriminating power |
|---|---|---|---|
| Genital development | Ambiguous genitalia may occur from disordered sex-steroid synthesis. | Genital ambiguity is not established as a typical feature. | Moderate |
| Salt balance | Salt-wasting crisis may occur and can be life-threatening. | Salt wasting is not a described core feature. | High |
| Development | Primary presentation is endocrine rather than developmental. | Developmental delay and distinctive facial features may occur. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with salt-wasting or adrenal crisis
Suggests disordered adrenal steroid production needing urgent endocrine evaluation.
High
Ambiguous genitalia with hormonal imbalance
Fits a steroidogenesis disorder better than a microdeletion.
Moderate
Abnormal adrenal steroid profile
Supports targeted genetic testing for HSD3B2-related disease.
Moderate
Choose 17q24 2 Microdeletion Syndrome C5680185 when
Developmental delay with congenital anomalies
A chromosomal microarray is more relevant than adrenal enzyme testing.
Moderate
Multiple features without endocrine crisis
A contiguous-gene deletion may explain a broader phenotype.
Low
Known chromosome 17 deletion
Confirms the microdeletion diagnosis when clinically correlated.
High
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 17q24 2 Microdeletion Syndrome C5680185 | Interpretation |
|---|---|---|---|
| Adrenal steroid profile | May show disordered steroid precursors; exact cutoffs are not established here. | No characteristic adrenal pattern is established. | Abnormal results suggest endocrine disease but require specialist confirmation. |
| Genetic testing | HSD3B2 sequencing may identify causative variants. | Chromosomal microarray may detect a 17q24.2 deletion. | Test choice should follow the clinical phenotype. |
| Electrolytes | Sodium and potassium may be abnormal during salt wasting. | No specific electrolyte pattern is established. | Electrolyte changes are urgent findings, not a standalone diagnosis. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Chronic condition; outcome depends on crisis prevention and hormone management, but mortality is not established here.
- Factors
- Salt wasting, illness, treatment adherence, and specialist monitoring.
17q24 2 Microdeletion Syndrome C5680185
- Outcome
- Chronic congenital condition with variable developmental and medical needs.
- Factors
- Deletion extent, associated anomalies, developmental support, and comorbidities.
Time frame: Lifelong follow-up is generally expected; exact course is not established.
Early recognition, individualized care, and avoidance of unsupported predictions.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal crisis | Possible, especially with salt wasting or illness. Not established as characteristic. Suspected crisis needs emergency care. |
| Developmental impairment | Not the primary described feature. Developmental delay may occur. Severity varies and is not predictable from these data. |
| Associated congenital issues | Mainly genital and hormonal effects are described. Facial features and other medical issues may occur. Specific complications should be assessed individually. |
Patient education highlights
- HighUrgent symptoms
Seek emergency care for vomiting, lethargy, dehydration, or suspected adrenal crisis.
- MediumDiagnosis
Genetic and hormone results need specialist interpretation; neither condition is contagious.
- MediumCare plan
Left-sided disease may need hormone replacement and monitoring; right-sided care is supportive and multidisciplinary.